Works matching IS 02780232 AND DT 2012 AND VI 30 AND IP 2

Results: 9

Polymorphisms of VEGF, GSTM1 and GSTT1 genes in multiple myeloma risk.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 105, doi. 10.1002/hon.1009

By:

Faber, Eliel W.;
Lourenço, Gustavo J.;
Ortega, Manoela M.;
Lorand-Metze, Irene;
De Souza, Carmino A.;
Lima, Carmen S. P.

Publication type:

Article

Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 82, doi. 10.1002/hon.1001

By:

Kako, Shinichi;
Nakasone, Hideki;
Endo, Hiroshi;
Sakamoto, Kana;
Ashizawa, Masahiro;
Sato, Miki;
Terasako, Kiriko;
Kikuchi, Misato;
Kimura, Shun-ichi;
Okuda, Shinya;
Yamazaki, Rie;
Oshima, Kumi;
Tanihara, Aki;
Nishida, Junji;
Usuki, Kensuke;
Kanda, Yoshinobu

Publication type:

Article

Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 101, doi. 10.1002/hon.1005

By:

Baumann, Michael;
Cerny, Thomas;
Sommacal, Andreas;
Koeberle, Dieter

Publication type:

Article

Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 98, doi. 10.1002/hon.1004

By:

Magyari, Ferenc;
Simon, Zsofia;
Barna, Sandor;
Udvardy, Miklos;
Váróczy, László;
Illés, Árpád

Publication type:

Article

Extracellular ATP induces CD44 shedding from macrophage-like P388D1 cells via the P2X7 receptor.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 70, doi. 10.1002/hon.1008

By:

Lin, Changwei;
Ren, Shuangyi;
Zhang, Li;
Jin, Hongfei;
Sun, Jianguo;
Zuo, Yunfei

Publication type:

Article

Overexpression of apoptosis-associated speck-like protein in P388D1 murine lymphoma cells affects metastatic properties.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 62, doi. 10.1002/hon.1010

By:

Zhang, Yi;
Zhang, Jian;
Lin, Changwei;
Wei, Wei;
Ren, Shuangyi;
Zuo, Yunfei

Publication type:

Article

Novel agents-based regimens as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 57, doi. 10.1002/hon.1007

By:

Wang, Lida;
Ran, Xuehong;
Wang, Baohong;
Sheng, Zhixin;
Liu, Liping

Publication type:

Article

Epidermal growth factor receptor expression in acute myelogenous leukaemia is associated with clinical prognosis.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 89, doi. 10.1002/hon.1002

By:

Sun, Jun-Zhong;
Lu, Ying;
Xu, Yin;
Liu, Fang;
Li, Fu-Quan;
Wang, Quan-Li;
Wu, Chu-Tse;
Hu, Xian-Wen;
Duan, Hai-Feng

Publication type:

Article

Azacitidine has limited activity in 'real life' patients with MDS and AML: a single centre experience.

Published in:

Hematological Oncology, 2012, v. 30, n. 2, p. 76, doi. 10.1002/hon.986

By:

Ozbalak, Murat;
Cetiner, Mustafa;
Bekoz, Huseyin;
Atesoglu, Elif Birtas;
Ar, Cem;
Salihoglu, Ayse;
Tuzuner, Nukhet;
Ferhanoglu, Burhan

Publication type:

Article